Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

FAP-1: a protein tyrosine phosphatase that associates with Fas.

Sato T, Irie S, Kitada S, Reed JC.

Science. 1995 Apr 21;268(5209):411-5.

PMID:
7536343
2.
3.

The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis.

Yanagisawa J, Takahashi M, Kanki H, Yano-Yanagisawa H, Tazunoki T, Sawa E, Nishitoba T, Kamishohara M, Kobayashi E, Kataoka S, Sato T.

J Biol Chem. 1997 Mar 28;272(13):8539-45.

4.

FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.

Wieckowski E, Atarashi Y, Stanson J, Sato TA, Whiteside TL.

J Cell Biochem. 2007 Jan 1;100(1):16-28.

PMID:
16888780
5.

Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis.

Su X, Zhou T, Wang Z, Yang P, Jope RS, Mountz JD.

Immunity. 1995 Apr;2(4):353-62.

PMID:
7536621
6.

Fas-associated phosphatase-1 promotes Fas-mediated apoptosis in human colon cancer cells: novel function of FAP-1.

Miyazaki T, Atarashi Y, Yasumura S, Minatoya I, Ogawa K, Iwamoto M, Minemura M, Shimizu Y, Sato TA, Watanabe A, Sugiyama T.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):84-91.

PMID:
16706817
7.

Identification of IkappaBalpha as a substrate of Fas-associated phosphatase-1.

Nakai Y, Irie S, Sato TA.

Eur J Biochem. 2000 Dec;267(24):7170-5.

8.

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Suda T, Takahashi T, Golstein P, Nagata S.

Cell. 1993 Dec 17;75(6):1169-78.

PMID:
7505205
9.
10.

[Development of anti cancer drugs targeted on Fas-mediated apoptosis signal].

Takahashi M, Kataoka S.

Gan To Kagaku Ryoho. 1997 Jan;24(2):222-8. Review. Japanese.

PMID:
9030235
11.
12.

FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS.

Foehr ED, Lorente G, Vincent V, Nikolich K, Urfer R.

J Neurooncol. 2005 Sep;74(3):241-8.

PMID:
16187021
13.

FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis.

Ungefroren H, Kruse ML, Trauzold A, Roeschmann S, Roeder C, Arlt A, Henne-Bruns D, Kalthoff H.

J Cell Sci. 2001 Aug;114(Pt 15):2735-46.

14.

Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation.

Irie S, Hachiya T, Rabizadeh S, Maruyama W, Mukai J, Li Y, Reed JC, Bredesen DE, Sato TA.

FEBS Lett. 1999 Oct 29;460(2):191-8.

15.
16.

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM.

Cell. 1995 May 19;81(4):505-12.

17.

Characterization and chromosomal localization of PTPRO, a novel receptor protein tyrosine phosphatase, expressed in hematopoietic stem cells.

Avraham S, London R, Tulloch GA, Ellis M, Fu Y, Jiang S, White RA, Painter C, Steinberger AA, Avraham H.

Gene. 1997 Dec 19;204(1-2):5-16.

PMID:
9434160
18.

Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues.

Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Lee JH, Han SY, Lee HK, Park JY, Oh RR, Jang JJ, Lee JY, Yoo NJ.

APMIS. 1999 Dec;107(12):1101-8.

PMID:
10660140
19.

Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway.

Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Fujimura T, Ninomiya I, Fushida S, Nishimura GI, Shimizu K, Miwa K.

Int J Oncol. 2001 Feb;18(2):311-6.

PMID:
11172597
20.

Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL.

Chen J, Zhang H, Su F, Min J, Zhang J, Song E.

Asian J Surg. 2002 Jan;25(1):89-97.

PMID:
17585452
Items per page

Supplemental Content

Write to the Help Desk